Together, the results demonstrate that HDAC1 is modified by SUMO-1 and this modification can dramatically affect HDAC1 activity in a number of surrogate biological assays.
INTRODUCTION
The mechanistic relationship between core histone modification and the regulation of gene expression continues to be a central focus in the field of transcription. Prominent among these modifications is the acetylation/deacetylation of histone tails and their apparent pervasive roles in diverse cellular processes such as growth, differentiation, apoptosis, and transformation (1) .
Deacetylation of the N-terminus of histone tails by histone deacetylases (HDACs) has been shown to inhibit transcriptional activation, supporting the prevailing model that this modification converts chromatin into a "closed-conformation" impeding progression of the transcriptional machinery along the DNA (2) . Recently, specific inhibitors of histone deacetylation have been shown to affect growth or survival of transformed cells (3) and to exhibit clinical efficacy in human hematopoietic malignancies (4) . These anti-neoplastic effects are presumably mediated in part by modulating the transcriptional regulation of many genes and trans-acting proteins governing growth and differentiation (5) .
To date, the mammalian genome contains at least 10 HDACs that fall into one of two classes: Class I HDACs 1 -3 and 8 with structural relatedness to the yeast HDAC ortholog, rpd3; and Class II HDACs 4 -7, 9 and 10 bearing relatedness to the yeast protein, hda1 (6) (7) (8) (9) . HDACs 1 and 2 have been shown to be integral components of at least 3 distinct multi-protein co-repressor complexes: mSin3, NuRD and CoRest complexes. The mSin3 complex contains mSin3A and B, RbAp46 and RbAp48, SAP30 and SAP18, and mSds3 and is recruited to specific gene targets via direct interaction between mSin3 and sequence-specific transcription factors such as Mad(Mxi1) family members (10, 11 and references therein). Tethering the mSin3 complex by guest on http://www.jbc.org/ Downloaded from recruits HDAC activity to specific promoters and is thought to result in the local deacetylation of histones N-terminal tails and active repression of gene transcription (12) . Another HDAC1/2-containing complex is NuRD, comprised of Mi-2, MBD3, MTA2, and also RbAP46 and 48. In addition to HDAC activity, this complex exhibits ATP-dependent nucleosome remodeling activity and is believed to participate in the stable repression of several genomic loci (13) (14) (15) (16) .
Finally, a new HDAC1/2-containing complex, the CoRest complex, was recently described and appears to play an important role in the active repression of genes essential to the neural phenotype (17) .
Beyond recruitment to specific co-repressor complexes, the mechanisms governing HDAC1 activity are not well understood. Here, we examined whether HDAC1 is subject to post-translational modifications and whether such modification correlates with altered HDAC1 activity and association with the mSin3 co-repressor. Given the lysine-rich nature of HDAC1, we focused on covalent modifications by ubiquitin or SUMO-1 (small ubiquitin-related modifier) -modifications known to target lysine residues. SUMO-1 is a 16 kDa protein bearing 18% identity with ubiquitin and requiring a conjugation machinery similar to that of ubiquitin: E1 activation enzymes (Aos1/Uba1), E2 conjugation enzymes (mUbc9) and E3 ligases (18, 19) . The number of substrates modified by SUMO-1 has grown considerably and, in each instance, SUMO-1 modification has been shown to exert profound and varied effects on the target protein including inhibition of ubiquitination, control of localization to sub-cellular compartments, and/or modulation of enzymatic activity (18, 19) . In this study, we show that specific lysine residues present in the HDAC1 C-terminus are modified by both ubiquitin and SUMO-1 and that by guest on http://www.jbc.org/ Downloaded from mutational analysis of these target residues can exert a significant impact on HDAC1 activity in a series of surrogate functional assays.
MATERIALS AND METHODS

Antibodies and plasmids.
For endogenous HDAC1 detection, the anti-HDAC1 antibody was purchased from Upstate Biotechnology and diluted 1 to 2000. Endogenous mSin3A was detected using the anti-mSin3A antibody K20 (Santa Cruz) diluted 1 to 200. The FLAG-tagged constructs were detected using the M2 antibody (SIGMA), diluted 1 to 2000. The mouse HDAC1-FLAG cDNA expression vector provided by Eric Verdin (20) was placed in the pCDNA3.1 vector (Invitrogen) and utilized in both transfection and in vitro translation studies. HDAC1 mutants were generated by site-directed mutagenesis (Stratagene) and confirmed by DNA sequencing.
The plasmids encoding Ubi HIS , SUMO-1 HIS , SUMO-1-HA and GST-mUbc9 were kindly provided by Drs Dirk Bohman and Anne Dejean. GST-SUMO-1 encoding plasmid was generated by cloning a PCR-generated SUMO-1 fragment in which the two C-terminal glycines of SUMO-1 are removed and placed in-frame with bridging oligonucleotides into the pGEX-5X vector (Promega). HDAC1 and HDAC1 mutant cDNAs were fused to GAL4 DNA Binding Domain (residues 1-147) in pGAL0 using appropriate primers and PCR and were confirmed by DNA sequencing. The retroviruses were generated by cloning HDAC1 and HDAC1 mutant into a modified pBABE containing an IRES-GFP cassette.
Cell culture and transfection. 293T cells and NIH 3T3 cells were grown using standard conditions in DMEM medium supplemented with 10% fetal calf serum. Transfections were performed using Lipofectamine Plus (Invitrogen) according to the manufacturer instructions. For reporter assays, 7 X 10 4 cells were transfected with 0.1 µg tk-(GAL4) 5 -luc reporter plasmid, 0.1 µg pGAL4 or derivatives derivatives, and 0.1 µg pCMX-LacZ. Trichostatin A (TSA) was purchased from SIGMA and cells were treated with 100ng/µl for 16 hours. Cells were lysed and luciferase activity was determined using a Luciferase reporter assay kit (Promega), and normalized for transfection efficiency using β-GAL activity. Retroviral infections were performed using standard procedures. For immuno-precipitation, cells were lysed in PBS plus 0.5% NP40, incubated for 3 hours with anti-Flag antibody and protein-A/G Plus agarose beads (Santa Cruz), and extensively washed in PBS plus 0.5% NP40.
In vitro and in vivo modification assays. In vitro modification assays were performed as described by Desterro et al. (21) . In vivo modification were performed as described by Muller et al., after transfection of 293T cells with the appropriate plasmids (22) . 
RESULTS AND DISCUSSION
HDAC1 is modified by
